For more information or confidential assistance
Call 800-306-3180

Lipitor Multidistrict Litigation Updates

The prescription drug Lipitor (atorvastatin calcium) has been prescribed in thousands of patients across the United States for treatment of elevated LDL-cholesterol. Despite its position as the number one selling drug of all time, Lipitor is not without drawbacks – including the increased risk of... Read More

Another Generic Lipitor Recall Issued

Lipitor
A generic Lipitor recall has been issued by India’s largest drugmaker, Ranbaxy Laboratories, Ltd. More than 64,000 bottles of the generic cholesterol-lowering drug have been recalled, following regulatory concerns on the manufacturing quality of the drug, after a dosage error was identified. According to the... Read More

New Study Highlights Statins and Diabetes Risk

Lipitor
Cholesterol lowering drugs, known as statins, and their potential side effects have been the topic of concern among health care practitioners, the FDA and consumers, as emerging research finds more evidence of serious risks.  In 2012, the FDA announced updates on statin risks for Pfizer’s... Read More